ClinicalTrials.gg

Drug

Napabucasin clinical trials

Also written BBI608 and BB608.

studies test it
16
open now
0
in phase 3
5
first study started
2009

How studies write it

Studies that test it under each name

Name

Napabucasin
11

Development codes

BBI608
16
BB608
8

Studies by the year they started

16 studies that test it; most in 2015 (5)

Studies that test napabucasin, by start year
YearStudies
20091
20111
20131
20142
20155
20163
20171
20182

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
5
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 14 · Other 2

Sumitomo Pharma America, Inc. (11) · Sumitomo Pharma Co., Ltd. (3) · NCIC Clinical Trials Group (1) · Australasian Gastro-Intestinal Trials Group (1)

Often tested with

Tested in the same studies.

Amcasertib (2) · Paclitaxel (1) · Temozolomide (1) · Bevacizumab (1) · Pemetrexed (1) · Cisplatin (1) · Sorafenib (1) · BNC 105 (1)

Studies

Open first, then newest update. How each study uses napabucasin is read from its arms, and is right about nine times in ten.

Testing it · 16

Given in every arm · 8 — napabucasin is usual care beside what is tested

Codes

What other systems call napabucasin · ClinicalTrials.gg INT000728

  • UNII (FDA) Z1HHM49K7ONAPABUCASINConfirmed FDA, Wikidata
  • Wikidata Q27294876napabucasinConfirmed FDA, Wikidata
  • NCI Thesaurus C96429NapabucasinOne source FDA
  • DrugBank DB12155One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.